Variable Interest Entities - Revenue and Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Variable Interest Entity [Line Items] | |||||||||||
| Total revenues | $ 288,963 | $ 288,898 | $ 265,362 | $ 266,446 | $ 117,594 | $ 74,462 | $ 57,478 | $ 71,293 | $ 1,109,669 | $ 320,827 | $ 79,272 |
| Claims expense | (266,404) | (264,283) | (238,764) | (247,552) | (104,026) | (51,298) | (40,384) | (23,917) | (1,017,003) | (219,625) | (25,120) |
| Clinical care delivery expense | (16,543) | (18,505) | (21,649) | (23,927) | (24,957) | (17,038) | (16,013) | (11,823) | (80,624) | (69,831) | (42,134) |
| Sales, general & administrative expenses | (53,311) | (54,474) | (64,503) | (55,649) | (73,176) | (39,257) | (43,753) | (30,986) | (227,937) | (187,172) | (90,687) |
| Depreciation and amortization expenses | (2,610) | (2,456) | (3,906) | (3,078) | (4,503) | (2,659) | (1,310) | (713) | (12,050) | (9,185) | (3,955) |
| Impairment expense | 38,599 | 647 | 24,820 | 0 | 0 | 0 | 0 | 0 | 64,066 | 0 | 0 |
| Premium deficiency reserve income / (expense) | $ 7,538 | $ 21,518 | $ 9,123 | $ (6,868) | $ (48,199) | $ 2,870 | $ (25) | $ (1,179) | 31,311 | (46,533) | (5,639) |
| Variable Interest Entity, Primary Beneficiary | |||||||||||
| Variable Interest Entity [Line Items] | |||||||||||
| Total revenues | 480,925 | 154,508 | 17,436 | ||||||||
| Claims expense | (462,226) | (135,674) | (16,007) | ||||||||
| Clinical care delivery expense | (38,787) | (19,517) | (4,168) | ||||||||
| Sales, general & administrative expenses | (37,027) | (47,354) | (2,809) | ||||||||
| Depreciation and amortization expenses | (2,049) | (7,652) | (989) | ||||||||
| Impairment expense | 0 | 0 | 0 | ||||||||
| Premium deficiency reserve income / (expense) | $ 16,077 | $ (30,814) | $ 0 | ||||||||
| X | ||||||||||
- Definition Clinical Care Delivery Expense No definition available.
|
| X | ||||||||||
- Definition Premium Deficiency Reserve Income (Expense) No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|